Advertisement

Topics

Goodwin Publishes Report on Significant Developments in Life Sciences and Health Care Securities Litigation in the First Circuit

09:38 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Goodwin, a leading Global 50 law firm, announced today the release of 2016 Year In Review - Securities Litigation Against Life Sciences and Health Care Companies In The First Circuit, a report highlighting major securities class...

Other Sources for this Article

Goodwin
Somna Maraj, 212-859-7212
smaraj@goodwinlaw.com

NEXT ARTICLE

More From BioPortfolio on "Goodwin Publishes Report on Significant Developments in Life Sciences and Health Care Securities Litigation in the First Circuit"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...